| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/05/2013 | US8389281 Materials and methods relating to the production and maintenance of cell lines |
| 03/05/2013 | US8389275 Fusion proteins of HIV regulatory/accessory proteins |
| 03/05/2013 | US8389251 Method for producing methionine using a microorganism with reduced expression activity of a negative regulator of methionine biosynthesis |
| 03/05/2013 | US8389242 Process for producing Apo2L |
| 03/05/2013 | US8389039 Process for preparing bioactive protein-enriched whey products |
| 03/05/2013 | US8389010 Stretchable collagen material and manufacturing method and use thereof |
| 03/05/2013 | US8388981 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesiosis |
| 03/05/2013 | US8388975 Cancer antigen peptides derived from WT1 |
| 03/05/2013 | US8388963 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof |
| 03/05/2013 | US8388951 Method for treating systemic DNA mutation disease |
| 03/05/2013 | US8388942 Methods of interferon-β purification and recovery |
| 03/05/2013 | US8388933 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 03/05/2013 | CA2659180C Trichoderma reesei swollenin protein and encoding dna sequences |
| 03/05/2013 | CA2595610C Antibodies directed to angiopoietin-2 and uses thereof |
| 03/05/2013 | CA2528240C Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof |
| 03/05/2013 | CA2335340C Fsh and fsh variant formulations, products and methods |
| 02/28/2013 | WO2013029030A1 New aav capsid proteins for nucleic acid transfer |
| 02/28/2013 | WO2013028843A1 Peptide nanoparticles and uses thereof |
| 02/28/2013 | WO2013028817A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | WO2013028541A1 Vegf-binding protein for blockade of angiogenesis |
| 02/28/2013 | WO2013028527A1 Compositions and methods for treating cancer |
| 02/28/2013 | WO2013028278A1 Cellobiohydrolase variants |
| 02/28/2013 | WO2013028048A1 Development, from amino acids having a high molecular weight, of a chelate provided in a gel state and having silver, copper and zinc ions in order to increase the effectiveness of treating various types of sewage |
| 02/28/2013 | WO2013027191A1 Methods and compositions using fgf23 fusion polypeptides |
| 02/28/2013 | WO2013027158A1 Methods of increasing protein, oil, and/or amino acid content in plants |
| 02/28/2013 | WO2013026860A1 Shortened tetranectin-apolipoprotein a-i fusion protein, a lipid particle containing it, and uses thereof |
| 02/28/2013 | WO2013026794A1 Novel immunomodulatory peptide |
| 02/28/2013 | WO2013026452A1 Method for removing immunosuppresive properties of hiv envelope glycoproteins |
| 02/28/2013 | WO2013026157A1 Anti-cancer peptides and uses thereof |
| 02/28/2013 | WO2013026105A1 Pest-controlling agents isolated from spider venom and uses thereof |
| 02/28/2013 | WO2013026089A1 Peptides for use in the treatment of il-1 related diseases and conditions |
| 02/28/2013 | WO2012174397A3 Anti-inflammatory pharmaceutical products |
| 02/28/2013 | WO2012140677A3 ISOLATION, CLONING, SEQUENCING AND FUNCTIONAL ANALYSIS OF β-CASEIN PROMOTER ALONG WITH THE REGIONS OF EXON1, INTRON1 AND EXON2 USING MAMMARY GLAND DERIVED CELL LINE OF BUFFALO (BUBULUS BUBALIS) |
| 02/28/2013 | WO2012117336A9 Apoptosis-inducing molecules and uses therefor |
| 02/28/2013 | WO2011151326A3 The use of transporters to modulate flavor production by yeast |
| 02/28/2013 | US20130053550 Yeast strains producing mammalian-like complex n-glycans |
| 02/28/2013 | US20130053548 Protein A Crystals and Cross-Linked Crystals and Methods of Use Thereof |
| 02/28/2013 | US20130053546 Use of Anticoagulants in the Production of Recombinant Proteins in the Milk of Transgenic Animals |
| 02/28/2013 | US20130053545 Identifying components of a network having high importance for network integrity |
| 02/28/2013 | US20130053431 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 02/28/2013 | US20130053330 Fertilization Prediction and Promotion |
| 02/28/2013 | US20130053327 Polypeptide expressed in the stratum corneum and use thereof |
| 02/28/2013 | US20130053324 Novel self-assembling peptides and their use in the formation of hydrogels |
| 02/28/2013 | US20130053323 Methods and use related to humanin and humanin-like peptides |
| 02/28/2013 | US20130053322 Hsa-related compositions and methods of use |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/28/2013 | US20130053314 Mutant Epidermal Growth Factor Polypeptides with Improved Biological Activity and Methods of Their Making and Use |
| 02/28/2013 | US20130053312 Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes |
| 02/28/2013 | US20130053311 Glp-1 analogues and derivatives |
| 02/28/2013 | US20130053310 Novel glucagon analogues |
| 02/28/2013 | US20130053304 Glucagon-like peptide-1 analogues and uses thereof |
| 02/28/2013 | US20130053271 Self-Assembled Bead-Based Multiplexed Assay For Antigen-Specific Antibodies |
| 02/28/2013 | US20130052667 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/28/2013 | US20130052663 Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors |
| 02/28/2013 | US20130052654 Amyloid Precursor Protein E2 Domain and Uses Thereof |
| 02/28/2013 | US20130052634 Hcv genotype 4 replicons |
| 02/28/2013 | US20130052633 Hcv genotype 3 replicons |
| 02/28/2013 | US20130052229 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 02/28/2013 | US20130052227 Hyperblebbing shigella strains |
| 02/28/2013 | US20130052218 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |
| 02/28/2013 | US20130052214 Identification of a peptide(s) that induces autoimmune anterior uveitis |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052210 Use of ccl1 in therapy |
| 02/28/2013 | US20130052163 Human Rhinovirus (HRV) Antibodies |
| 02/28/2013 | US20130052160 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/28/2013 | US20130052159 Methods for treatment of microbial disorders |
| 02/28/2013 | US20130052157 Use of il-17e for cancer treatment |
| 02/28/2013 | US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof |
| 02/28/2013 | US20130052132 Method for Producing Radioactively Labeled Polypeptide |
| 02/28/2013 | US20130052130 Branched Discreet PEG Constructs |
| 02/28/2013 | DE102011081524A1 Coating a substrate with a monolayer of self-assembling proteins, comprises providing stabilized aqueous solutions with self-assembling proteins, and contacting a surface of the substrate with the stabilized protein-containing solution |
| 02/28/2013 | DE102010039018B4 Anti-La Antikörper und ihre Anwendung zum Immunotargeting Anti-La antibodies and their application to Immunotargeting |
| 02/28/2013 | DE102006021722B4 Oligonukleotidsonden, Peptide, Verfahren und Kits zur Anreicherung, Immobilisierung, zum Nachweis oder zur Detektion von Erwinia amylovora Oligonucleotide probes, peptides, methods and kits for the enrichment, immobilization, detection, or for detection of Erwinia amylovora |
| 02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | CA2846092A1 Peg-interferon lambda 1 conjugates |
| 02/28/2013 | CA2845886A1 Peptide nanoparticles and uses thereof |
| 02/28/2013 | CA2845682A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
| 02/28/2013 | CA2844913A1 Integrated method for high-throughput identification of novel pesticidal compositions and uses therefor |
| 02/28/2013 | CA2844779A1 Neurogenic and gliogenic factors and assays therefor |
| 02/28/2013 | CA2838070A1 Shortened tetranectin-apolipoprotein a-i fusion protein, a lipid particle containing it, and uses thereof |
| 02/27/2013 | EP2562259A2 Transgenic plants with enhanced agronomic traits |
| 02/27/2013 | EP2562184A1 Novel immunogenic epitopes for immunotherapy |
| 02/27/2013 | EP2562183A1 Novel immunogenic epitopes for immunotherapy |
| 02/27/2013 | EP2562182A1 Novel immunogenic epitopes for immunotherapy |
| 02/27/2013 | EP2561884A1 Chimeric VEGF peptides |
| 02/27/2013 | EP2561359A1 Chimeric polypeptides useful in proximal and dynamic high-throughput screening methods |
| 02/27/2013 | EP2561105A1 Mutant strains of escherichia coli, a method of testing potential antibacterial agents using said strains as well as a testing kit |
| 02/27/2013 | EP2561070A1 New stabilizing agent for pharmaceutical proteins |
| 02/27/2013 | EP2561064A1 Cell suitable for fermentation of a mixed sugar composition |
| 02/27/2013 | EP2561063A1 A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5 |
| 02/27/2013 | EP2560991A1 Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
| 02/27/2013 | EP2560990A1 Novel allergen |
| 02/27/2013 | EP2560989A1 Cancer-related glycopeptide epitopes, antibodies and methods of use |
| 02/27/2013 | EP2560988A1 Process for the production of cells which are capable of converting arabinose |
| 02/27/2013 | EP2560987A1 Biocatalytic oxidation process with alkl gene product |
| 02/27/2013 | EP2560986A1 Genetically modified sendai virus for treatment of tumours |
| 02/27/2013 | EP2560985A1 Nucleic acid sequences of a fish virus and the use thereof |
| 02/27/2013 | EP2560983A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 02/27/2013 | EP2560738A1 Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels |
| 02/27/2013 | EP2560689A1 Novel self-assembling peptides and their use in the formation of hydrogels |